[1] Williams MJA, Poulton R, Williams S. Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis, 2002; 165, 179−84. doi:  10.1016/S0021-9150(02)00233-2
[2] Mikkelsen LF, Nordestgaard BG, Schnohr P, et al. Increased ferritin concentration and risk of atrial fibrillation and heart failure in men and women: three studies of the Danish general population including 35799 individuals. Clin Chem, 2019; 65, 180−8. doi:  10.1373/clinchem.2018.292763
[3] Zacharski LR, Shamayeva G, Chow BK, et al. Ferritin and percent transferrin saturation levels predict type 2 diabetes risk and cardiovascular disease outcomes. Curr Diabetes Rev, 2017; 13, 428−36.
[4] Kalantar-Zadeh K, Kalantar-Zadeh K, Lee GH. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? Clin J Am Soc Nephrol, 2006; 1 Suppl 1, S9−18.
[5] Cho MR, Park JK, Choi WJ, et al. Serum ferritin level is positively associated with insulin resistance and metabolic syndrome in postmenopausal women: a nationwide population-based study. Maturitas, 2017; 103, 3−7. doi:  10.1016/j.maturitas.2017.06.004
[6] Tang Q, Liu ZF, Tang Y, et al. High serum ferritin level is an independent risk factor for metabolic syndrome in a Chinese male cohort population. Diabetol Metab Syndr, 2015; 7, 11. doi:  10.1186/s13098-015-0004-9
[7] Ledesma M, Hurtado-Roca Y, Leon M, et al. Association of ferritin elevation and metabolic syndrome in males. Results from the Aragon workers' health study (AWHS). J Clin Endocrinol Metab, 2015; 100, 2081−9. doi:  10.1210/jc.2014-4409
[8] Yoon JH, Linton JA, Koh SB, et al. Serum ferritin concentrations predict incidence of metabolic syndrome in rural Korean adults. Clin Chem Lab Med, 2012; 50, 2057−9.
[9] Wang M, Zhao A, Szeto IMY, et al. Association of serum ferritin with metabolic syndrome in eight cities in China increased ferritin concentration and risk of atrial fibrillation and heart failure in men and women: three studies of the danish general population including 35799 individuals. Food Sci Nutr, 2020; 65, 180−8.
[10] Kilani N, Vollenweider P, Waeber G, et al. Iron metabolism and incidence of metabolic syndrome. Nutr Metab Cardiovasc Dis, 2015; 25, 1025−32. doi:  10.1016/j.numecd.2015.07.005
[11] Jin YL, He LP, Chen Y, et al. Association between serum ferritin levels and metabolic syndrome: an updated meta-analysis. Int J Clin Exp Med, 2015; 8, 13317−22.
[12] Suarez-Ortegon MF, Ensaldo-Carrasco E, Shi T, et al. Ferritin, metabolic syndrome and its components: a systematic review and meta-analysis. Atherosclerosis, 2018; 275, 97−106. doi:  10.1016/j.atherosclerosis.2018.05.043
[13] Abril-Ulloa V, Flores-Mateo G, Solà-Alberich R, et al. Ferritin levels and risk of metabolic syndrome: meta-analysis of observational studies. BMC Public Health, 2014; 14, 483. doi:  10.1186/1471-2458-14-483
[14] Fang XX, Min JX, Wang FD. A dose-response association between serum ferritin and metabolic syndrome? Atherosclerosis, 2018; 279, 130−1. doi:  10.1016/j.atherosclerosis.2018.10.016
[15] Shim YS, Kang MJ, Oh YJ, et al. Association of serum ferritin with insulin resistance, abdominal obesity, and metabolic syndrome in Korean adolescent and adults: the Korean national health and nutrition examination survey, 2008 to 2011. Medicine, 2017; 96, e6179. doi:  10.1097/MD.0000000000006179
[16] Chen L, Li YF, Zhang F, et al. Association of serum ferritin levels with metabolic syndrome and insulin resistance in a Chinese population. J Diabetes Complicat, 2017; 31, 364−8. doi:  10.1016/j.jdiacomp.2016.06.018
[17] Suárez-Ortegón MF, McLachlan S, Wild SH, et al. Soluble transferrin receptor levels are positively associated with insulin resistance but not with the metabolic syndrome or its individual components. Br J Nutr, 2016; 116, 1165−74. doi:  10.1017/S0007114516002968
[18] Seo SK, Yun BH, Chon SJ, et al. Association of serum ferritin levels with metabolic syndrome and subclinical coronary atherosclerosis in postmenopausal Korean women. Clin Chim Acta, 2015; 438, 62−6. doi:  10.1016/j.cca.2014.07.042
[19] Kilani N, Waeber G, Vollenweider P, et al. Markers of iron metabolism and metabolic syndrome in Swiss adults. Nutr Metab Cardiovasc Dis, 2014; 24, e28−9. doi:  10.1016/j.numecd.2014.04.018
[20] Li J, Wang R, Luo D, et al. Association between serum ferritin levels and risk of the metabolic syndrome in Chinese adults: a population study. PLoS One, 2013; 8, e74168. doi:  10.1371/journal.pone.0074168
[21] Chang JS, Lin SM, Huang TC, et al. Serum ferritin and risk of the metabolic syndrome: a population-based study. Asia Pac J Clin Nutr, 2013; 22, 400−7.
[22] Ryoo JH, Kim MG, Lee DW, et al. The relationship between serum ferritin and metabolic syndrome in healthy Korean men. Diabetes Metab Res Rev, 2011; 27, 597−603. doi:  10.1002/dmrr.1211
[23] Cho GJ, Shin JH, Yi KW, et al. Serum ferritin levels are associated with metabolic syndrome in postmenopausal women but not in premenopausal women. Menopause, 2011; 18, 1120−4. doi:  10.1097/gme.0b013e318217e172
[24] Sun L, Franco OH, Hu FB, et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocrinol Metab, 2008; 93, 4690−6. doi:  10.1210/jc.2008-1159
[25] Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care, 2004; 27, 2422−8. doi:  10.2337/diacare.27.10.2422
[26] Smetana GW, Umscheid CA, Chang S, et al. Methods guide for authors of systematic reviews of medical tests: a collaboration between the agency for healthcare research and quality (AHRQ) and the journal of general internal medicine. J Gen Intern Med, 2012; 27, S1−3.
[27] Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 1959; 22, 719−48.
[28] DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials, 1986; 7, 177−88. doi:  10.1016/0197-2456(86)90046-2
[29] Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol, 1992; 135, 1301−9. doi:  10.1093/oxfordjournals.aje.a116237
[30] Chen GC, Tong X, Xu JY, et al. Whole-grain intake and total, cardiovascular, and cancer mortality: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr, 2016; 104, 164−72. doi:  10.3945/ajcn.115.122432
[31] Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997; 315, 629−34. doi:  10.1136/bmj.315.7109.629
[32] Klip IT, Voors AA, Swinkels DW, et al. Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community. Eur J Heart Fail, 2017; 19, 348−56. doi:  10.1002/ejhf.622
[33] Paramonov AD, Moiseev SV, Fomin VV, et al. Ferritin and other acute phase proteins in various forms of coronary heart disease. Klin Med (Mosk), 2005; 83, 25−9.
[34] Chen L, Li YF, Zhang F, et al. Elevated serum ferritin concentration is associated with incident type 2 diabetes mellitus in a Chinese population: a prospective cohort study. Diabetes Res Clin Pract, 2018; 139, 155−62. doi:  10.1016/j.diabres.2018.03.001
[35] Balla J, Balla G, Zarjou A. Ferritin in kidney and vascular related diseases: novel roles for an old player. Pharmaceuticals (Basel), 2019; 12, 96. doi:  10.3390/ph12020096
[36] Park SK, Choi WJ, Oh CM, et al. Association between serum ferritin levels and the incidence of obesity in Korean men: a prospective cohort study. Endocr J, 2014; 61, 215−24. doi:  10.1507/endocrj.EJ13-0173
[37] Ellidag HY, Eren E, Akdag M, et al. The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender. Ukr Biochem J, 2016; 88, 76−86. doi:  10.15407/ubj88.06.076
[38] Nakamura K, Sakurai M, Morikawa Y, et al. Serum Ferritin, insulin resistance, and β-cell dysfunction: a prospective study in normoglycemic Japanese men. Exp Clin Endocrinol Diabetes, 2017; 125, 12−20.
[39] Jamshidi-Naeini Y, Bavil AK, Egal A, et al. Hemoglobin and ferritin concentrations are positively associated with blood pressure and hypertension risk in older adults: a retrospective cross-sectional study, Sharpeville, South Africa. Asia Pac J Clin Nutr, 2019; 28, 533−43.
[40] Sharif K, Vieira BV, Zandman-Goddard G, et al. Eppur Si Muove: ferritin is essential in modulating inflammation. Clin Exp Immunol, 2018; 191, 149−50. doi:  10.1111/cei.13069
[41] Ruddell RG, Hoang-Le D, Barwood JM, et al. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology, 2009; 49, 887−900. doi:  10.1002/hep.22716
[42] Recalcati S, Invernizzi P, Arosio P, et al. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun, 2008; 30, 84−9. doi:  10.1016/j.jaut.2007.11.003
[43] Welty FK, Alfaddagh A, Elajami TK. Targeting inflammation in metabolic syndrome. Transl Res, 2016; 167, 257−80. doi:  10.1016/j.trsl.2015.06.017
[44] Cai DS, Liu TW. Inflammatory cause of metabolic syndrome via brain stress and NF-κB. Aging (Albany NY), 2012; 4, 98−115.
[45] Hayakawa M, Hattori K, Sugiyama S, et al. Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. Biochem Biophys Res Commun, 1992; 189, 979−85. doi:  10.1016/0006-291X(92)92300-M
[46] Kang JO. Chronic iron overload and toxicity: clinical chemistry perspective. Clin Lab Sci, 2001; 14, 209−19; quiz 222.
[47] Barciszewski J, Barciszewska MZ, Siboska G, et al. Some unusual nucleic acid bases are products of hydroxyl radical oxidation of DNA and RNA. Mol Biol Rep, 1999; 26, 231−8. doi:  10.1023/A:1007058602594
[48] Simcox JA, McClain DA. Iron and diabetes risk. Cell Metab, 2013; 17, 329−41. doi:  10.1016/j.cmet.2013.02.007
[49] Kell DB, Pretorius E. No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases. Biol Rev Camb Philos Soc, 2018; 93, 1518−57. doi:  10.1111/brv.12407
[50] Cheung BMY, Wat NMS, Man YB, et al. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2). Am J Hypertens, 2008; 21, 17−22. doi:  10.1038/ajh.2007.19
[51] Day SM, Duquaine D, Mundada LV, et al. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation, 2003; 107, 2601−6. doi:  10.1161/01.CIR.0000066910.02844.D0
[52] Van Der A DL, Marx JJM, Grobbee DE, et al. Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women. Circulation, 2006; 113, 1942−9. doi:  10.1161/CIRCULATIONAHA.105.545350
[53] Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet, 2005; 366, 1059−62. doi:  10.1016/S0140-6736(05)67402-8
[54] Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation, 2009; 120, 1640−5. doi:  10.1161/CIRCULATIONAHA.109.192644